Get started
Author

Repudi Lalitha

Observed name: R. Lalitha
Institution: Chaitanya
Observed institution: Chaitanya
ORCID: 0000-0002-1007-6397
Observed ORCID: 0000-0002-1007-6397
OpenAlex ID: A5073918769
A Validated RP-HPLC Method for Simultanious Determination of Metformin and Canagliflozin in Pharmaceutical Formulation
2018 · Gandla. Kumara Swamy, R. Lalitha, et al. · Asian Journal of Pharmaceutical Analysis · 16
Involving stemness factors to improve CAR T-cell-based cancer immunotherapy
2023 · Sara Abdalrazzaq M. Noraldeen, Irodakhon Rasulova, et al. · Medical Oncology · 12
Validated First Order Derivative Spectrophotometric Method for Simultaneous Estimation of Lansoprazole and Aspirin in Tablet Dosage Forms
2016 · G. Kumaraswamy, Repudi Lalitha, et al. · Asian Journal of Research in Pharmaceutical Sciences · 4
Method development and validation for estimation of rufinamide in tablet dosage forms by RP-HPLC
2016 · Gandla Kumaraswamy, Repudi Lalitha, et al. · International Journal of Pharmaceutical Chemistry and Analysis · 2
Method Development & Validation for the Simultaneous Estimation of Imipenem and Relebactum in Bulk and Phamraceutical Dosage Form by Uplc
2021 · Marta Sundari, Repudi Lalitha, et al. · International journal of advance research and innovative ideas in education · 1
Review on Role of Bioflavonoids in Treatment of Metabolic Syndrome
2026 · Uthukam Venkatesham, Repudi Lalitha · Zenodo (CERN European Organization for Nuclear Research)
Therapeutic Assessment of Topical Pirfenidone in a Murine Model of Imiquimod-induced Psoriasis
2026 · CH Sandeep Reddy, Repudi Lalitha · Journal of Pharmacology and Pharmacotherapeutics
Bioflavonoid Fisetin Treatment Prevents the High Fat Diet Induced Metabolic Syndrome in Wistar Rats
2026 · Uthukam Venkatesham, Repudi Lalitha · International Journal of Drug Delivery Technology
PDF
MX/M/1 Queueing System with N-Policy and Startup Time
2013 · Repudi Lalitha
Works count: 10
Citation count: 35
H-index: 3
I10-index: 2
Year
Topic
Type